Skip to main content
. 2023 Mar 14;12(6):2256. doi: 10.3390/jcm12062256

Table 1.

Prevalent serotypes of Streptococcus pneumoniae in NP.

Year Country No. PCV Use in National Immunity Program Prevalent Serotypes Pre-PCV Prevalent Serotypes Post-PCV PCV
Coverage
References
1997–2006 Utah 33 PCV-7: 2001, 2 + 1 Pre-PCV7: 6B (40.0%), 19F (20.0%), 1 (20.0%) and 6A (20.0%) Post-PCV7: 4 (3.6%), 1 (7.1%), 3 (39.3%), 7 (3.6%), 8 (3.6%), 17 (3.6%), 19 (14.3%) and 19A (14.3%) PCV-7: 80% [20]
2005–2019 Italy 43 PCV-13: 2010, 2 + 1 Pre-PCV13: 1 (18.2%), 3 (27.3%), 5 (9.1%), 7F (9.1%) and 19A (9.1%) Early post-PCV13: 1 (25.0%), 5 (12.5%) and 7F (12.5%)
Late post-PCV13: 3 (80.0%) and 12 (20.0%)
PCV-7: 62.8%
PCV-13: 23.3%
[23]
2012–2016 Catalonia, Spain 35 PCV-13: 2016, 2 + 1 Not mentioned Post-PCV13: 1 (14.3%), 3 (48.6%), 6B (2.9%), 7F (2.9%), 14 (5.7%), 19A (8.6%), 7A (5.7%), 6A/C (2.9%) and 12F/A/44/46 (2.9%) PCV-13: 14.3% [24]